Zhende Medical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	4,315	4,307	4,247	4,105	6,131	4,907
Other Revenue	23.05	23.05	16.67	21.6	6.47	184.42
Revenue	4,338	4,330	4,264	4,127	6,138	5,092
Revenue Growth (YoY)	1.09%	1.54%	3.32%	-32.76%	20.54%	-51.04%
Cost of Revenue	2,902	2,899	2,850	2,850	4,063	3,353
Gross Profit	1,437	1,431	1,414	1,277	2,075	1,738
Selling, General & Admin	933.94	926	890.18	894.44	984.23	808.32
Research & Development	139.55	142.43	135.49	138.95	227	153.14
Other Operating Expenses	22.59	23.22	2.92	8.15	41.8	48.33
Operating Expenses	1,109	1,105	1,039	1,043	1,262	1,011
Operating Income	328.29	326.11	375.05	233.3	812.89	727.2
Interest Expense	-34.21	-31.49	-28.73	-28.93	-33.54	-25.07
Interest & Investment Income	28.29	25.99	35.92	46.76	10.61	52.4
Currency Exchange Gain (Loss)	-4.59	-4.59	24.3	11.76	21.89	-15.69
Other Non Operating Income (Expenses)	-9.09	-4.11	-2.87	-1.98	-1.03	-2.07
EBT Excluding Unusual Items	308.7	311.92	403.68	260.9	810.81	736.77
Impairment of Goodwill	-	-	-	-2.29	-3.91	-
Gain (Loss) on Sale of Investments	9.37	0.63	-12.25	-21.06	-71.06	-2.7
Gain (Loss) on Sale of Assets	0.2	0.64	93.43	-15.96	-13.53	-0.61
Asset Writedown	2.48	1.8	-9.09	-52.02	-4.97	-3.31
Other Unusual Items	8.33	9.84	-0.31	49.34	84.38	89.81
Pretax Income	329.07	324.83	475.46	218.89	801.72	819.95
Income Tax Expense	56.81	57.73	78.25	5.49	99.96	99
Earnings From Continuing Operations	272.25	267.1	397.21	213.4	701.76	720.95
Minority Interest in Earnings	-8.23	-6.28	-12.04	-15	-21.88	-125.08
Net Income	264.02	260.82	385.17	198.4	679.88	595.86
Net Income to Common	264.02	260.82	385.17	198.4	679.88	595.86
Net Income Growth	-27.27%	-32.29%	94.14%	-70.82%	14.10%	-76.63%
Shares Outstanding (Basic)	264	263	266	268	237	226
Shares Outstanding (Diluted)	264	263	266	268	237	227
Shares Change (YoY)	-1.29%	-0.82%	-0.92%	13.18%	4.56%	11.08%
EPS (Basic)	1.00	0.99	1.45	0.74	2.87	2.64
EPS (Diluted)	1.00	0.99	1.45	0.74	2.87	2.63
EPS Growth	-26.32%	-31.72%	95.95%	-74.22%	9.13%	-78.96%
Free Cash Flow	140.68	-11.73	-308.55	-147.13	491.92	122.16
Free Cash Flow Per Share	0.53	-0.04	-1.16	-0.55	2.08	0.54
Dividend Per Share	0.300	0.300	0.650	1.250	-	0.600
Dividend Growth	-53.85%	-53.85%	-48.00%	-	-	-73.91%
Gross Margin	33.12%	33.05%	33.16%	30.93%	33.80%	34.14%
Operating Margin	7.57%	7.53%	8.80%	5.65%	13.24%	14.28%
Profit Margin	6.09%	6.02%	9.03%	4.81%	11.08%	11.70%
Free Cash Flow Margin	3.24%	-0.27%	-7.24%	-3.56%	8.02%	2.40%
EBITDA	626.54	614.01	621.58	476.27	998.26	858.7
EBITDA Margin	14.44%	14.18%	14.58%	11.54%	16.27%	16.86%
D&A For EBITDA	298.25	287.9	246.52	242.97	185.38	131.51
EBIT	328.29	326.11	375.05	233.3	812.89	727.2
EBIT Margin	7.57%	7.53%	8.80%	5.65%	13.24%	14.28%
Effective Tax Rate	17.27%	17.77%	16.46%	2.51%	12.47%	12.07%
Revenue as Reported	4,338	4,330	4,264	4,127	6,138	5,092
Advertising Expenses	-	21.21	42.83	38.17	39.94	20.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.